HOFSETH BIOCARE ASA

6003 ÅLESUND

Finances

Return on Equity

−92,81 %

Current Ratio

1,02

Debt-to-Equity Ratio

0,61

Key figures (NOK)	2022	2021	2020	2019
Revenue	120 448 000	87 616 000	69 252 000	67 778 000
Net Income	−137 390 000	−126 464 000	−102 091 000	−89 218 000
Total Assets	411 030 000	415 973 000	459 134 000	293 012 000
Total Equity	148 030 000	140 378 000	263 764 000	117 749 000

Income (NOK)	2022	2021	2020	2019
Revenue	120 448 000	87 616 000	69 252 000	67 778 000
Expenditure	249 066 000	206 180 000	161 273 000	147 352 000
Operating Profit	−128 618 000	−118 564 000	−92 021 000	−79 574 000
Financial Income	4 364 000	3 678 000	2 580 000	5 148 000
Financial Costs	13 136 000	11 578 000	12 650 000	14 792 000
Financial Balance	−8 772 000	−7 900 000	−10 070 000	−9 644 000
Earnings Before Tax	−137 390 000	−126 464 000	−102 091 000	−89 218 000
Tax	0	0	0	0
Net Income	−137 390 000	−126 464 000	−102 091 000	−89 218 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	235 281 000	245 662 000	187 664 000	155 160 000
Total Current Assets	175 749 000	170 311 000	271 470 000	137 852 000
Total Assets	411 030 000	415 973 000	459 134 000	293 012 000
Total Retained Equity	0	0	14 793 000	−208 216 000
Total Equity	148 030 000	140 378 000	263 764 000	117 749 000
Total Long-Term Debt	90 772 000	124 662 000	89 191 000	103 510 000
Total Current Debt	172 228 000	150 933 000	106 179 000	71 753 000
Total Equity and Debt	411 030 000	415 973 000	459 134 000	293 012 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	119 128 000	76 878 000	52 514 000	67 778 000
Other Income	1 320 000	10 738 000	16 738 000	0
Revenue	120 448 000	87 616 000	69 252 000	67 778 000
Cost of Goods Sold	91 934 000	64 517 000	39 532 000	59 570 000
Salary Costs	57 043 000	44 713 000	42 641 000	29 212 000
Depreciation	30 412 000	29 350 000	26 766 000	27 456 000
Impairment	0	0	0	0
Expenditure	249 066 000	206 180 000	161 273 000	147 352 000
Operating Profit	−128 618 000	−118 564 000	−92 021 000	−79 574 000
Financial Income	4 364 000	3 678 000	2 580 000	5 148 000
Financial Costs	13 136 000	11 578 000	12 650 000	14 792 000
Financial Balance	−8 772 000	−7 900 000	−10 070 000	−9 644 000
Dividends	0	0	0	0
Net Income	−137 390 000	−126 464 000	−102 091 000	−89 218 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	60 588 000	53 055 000	42 434 000	24 346 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	166 202 000	183 550 000	137 108 000	37 910 000
Fixtures	2 592 000	2 281 000	847 000	90 443 000
Total Tangible Assets	168 794 000	185 831 000	137 955 000	128 353 000
Total Fiancial Fixed Assets	5 899 000	6 776 000	7 275 000	2 461 000
Total Fixed Assets	235 281 000	245 662 000	187 664 000	155 160 000
Stock	116 525 000	90 813 000	73 302 000	33 986 000
Total Investments	0	0	0	0
Cash, Bank	32 428 000	49 921 000	172 835 000	94 553 000
Total Current Assets	175 749 000	170 311 000	271 470 000	137 852 000
Total Assets	411 030 000	415 973 000	459 134 000	293 012 000
Total Equity	148 030 000	140 378 000	263 764 000	117 749 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	90 772 000	124 662 000	89 191 000	103 510 000
Creditors	145 752 000	124 165 000	84 956 000	29 712 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	13 081 000	12 249 000	9 571 000	13 085 000
Total Current Debt	172 228 000	150 933 000	106 179 000	71 753 000
Total Equity and Debt	411 030 000	415 973 000	459 134 000	293 012 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−92,81 %	−90,09 %	−38,71 %	−75,77 %
Debt-to-Equity Ratio	0,61	0,89	0,34	0,88
Operating Profit Margin	−106,78 %	−135,32 %	−132,88 %	−117,4 %
Current Ratio	1,02	1,13	2,56	1,92
Quick Ratio	3,16	2,83	8,26	3,65
Equity Ratio	0,36	0,34	0,57	0,4
Gross Profit Margin	23,67 %	26,36 %	42,92 %	12,11 %